medigraphic.com

2001, Number 2

<< Back Next >>

Rev Med Hosp Gen Mex 2001; 64 (2)

Cardiopulmonary haemodynamic in chronic neumologic patients. A clinical comment

Cueto-Robledo G, Pérez-Rosales A, Escosura-Romero G, Navarro-Reynoso F, Mares-Gutiérrez Y, Torres-Pérez E, Pérez-Romo A, Cicero-Sabido R

Language: Spanish
References: 41
Page: 91-96
PDF size: 50.75 Kb.


ABSTRACT

Pulmonary chronic diseases are frequently associated with chronic cor pulmonale and pulmonary hypertension, both diseases have a poor survival prognosis. This article review the physiopathological causes of pulmonary hypertension in chronic pulmonary diseases, interstitial lung diseases and sleep obstructive apnea. The pulmonary hypertension have some etiological factors like than vasoactive factors (chronic hipoxia, acidosis, etc), passive factors (venocapilary hypertension, increased lung blood flow, obstruction and vascular damage). Other factors are decrease lung blood flow, increased of airway resistance and secondary erhytrocytosis. The knowledgment of the physiopathological factors of these diseases and the degree of the pulmonary hypertension must be documented from the study of the pulmonary circulation with right cardiac catheterism. This actions must be done in departments of hemodynamics in hospitals with teaching programs for lung physician.


REFERENCES

  1. MacNee. Right ventricular function in cor pulmonale. Cardiology 1988; suppl 1: 130-40.

  2. Weitzemblum E, Hirth C, Ducolone A, Mirhom R. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752-758.3. Sandoval J, Lupi H, Gaspar J, Stoane M, Casanova JM, Factores activos y pasivos en la génesis de la hipertensión arterial pulmonar en algunas cardiopatías y neumopatías. Arch Inst Cardiol Mex 1981; 51: 67-72.

  3. Sandoval J, Gomez A, Martinez ML, Cueto G, La hipertensión arterial pulmonar en las cardiopatías y las neumopatías. Neumol Cir Torax 1992; 51: 7-20.

  4. Harris P, Heath D. The human pulmonary circulation. New York: Churchill Livinstone Publisher, 1986.

  5. Meyrick B, and Reid L. Pulmonary hypertension, Anatomic And Physiologic Correlates. Clin Chest Med 1983; 4: 199-217.

  6. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease (part I). Am J Respir Crit Care Med 1994; 150: 833-852.

  7. Mc Grath RL, Weil JV. Adverse Effects of normovolemic polycythemia and hipoxia on haemodynamics in the dog. Circ Res 1978; 43: 793-798.

  8. FlenLey DC. Chronic obstructive pulmonary disease. DM 1988; 37: 566-599.

  9. E.Weitzenblum. The Pulmonary circulation and the heart in chronic lung disease. Monaldi Arch Chest Dis 1994; 49: 3, 235-238.

  10. Weitzenblum E. Loiseau A. Course of pulmonary haemodinamics in patients with chronic obstructive pulmonary disease. Chest 1979, 75: 656-662.

  11. A. Pezza, F de Blasio. Chronic bronchitis: reflex on the pulmonary circulation. Monaldi Arch Chest Dis 1994; 49:3, suppl. I, 27-32.

  12. Fishman AP. Hypertension and cor pulmonale. In: Fishman AP (ed). Pulmonary disease and disorders. 2nd ed. USA: MacGraw-Hill Book Company, 1988: 999-1011.

  13. Behnke RH, Blount SG, Bristo W. Primary prevention of pulmonary heart disease. Circulation 1970; A17-A23.

  14. Khaja F, Parker J. Right and left ventricular performance in COLD. Am Heart J 1971; 82: 319-327.

  15. Matthay RA, Beryer HJ. Cardiovascular performance in COPD. Clin Med North Am 1981; 65: 489-524.

  16. Stein PD, Sabbah AH. Ambe DT. Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertension. Am J Cardiol 1979; 44: 1050-1055.

  17. Sagawa K. The end-systolic pressure volumen relation of the ventricle: Definition, modifications and clinical use. Circulation 1981; 63: 1223-1227.

  18. Strobeck JE, Sonnenblick EH. Pathophysiology of the heart failure. In: Gaasch WH (ed). The ventricle. Boston: Martinus Nishoff Publ, 1985; 209-224.

  19. Lupi HE, Sandoval J. Pathogenesis of pulmonary arterial hypertension in intersticial lung disease. In: Selman M, Barrios R (eds). Selected topics. Chapter 12. Boca Raton, Ann Arbor, Boston: CRC Press, 1991; 283-300.

  20. Crystal RG, Gadek JE. Idiopathic pulmonary fibrosis. Ann Intern Med 1976; 85: 769-775.

  21. Rubin LJ. Pulmonary hypertension secondary to lung disease. In: Weir EK, Reeves JT (eds). Pulmonary hypertension. New York: Futura, 1984, 291.

  22. Stack HJ, Choo-Kank YF and Heard BC . The prognosis of criptogenic fibrosing alveolitis. Thorax 1972; 27: 535-539.

  23. Lupi HE, Vargas J, Salinas L. La hipertensión pulmonar en los trastornos de la difusión de oxígeno. Arch Inst Cardiol Mex 1978; 48: 779-785.

  24. Steven Kesten. End-stage lung disease and prediction of mortality. Semin Resp Crit Care Med 1996; 17: 423-435.

  25. Tilkian AG, Guilleminault C, Schroesder JS, Lehrman KL, Simmons FB. Hemodynamics in sleep-induced apnea. Ann Intern Med 1976; 85: 714-719.

  26. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome: Results in 220 consecutive patients. Chest 1996; 109: 308-386.

  27. Weitzenblum E, Krieger J, April M. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988; 138: 345-49.

  28. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995; 107: 1538-1544.

  29. Bradley TD, Rutherford R, Grosmann RF. Role of daytime hipoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985; 131: 835-839.

  30. Widimsky J, Ostadal G, Urbanova D, Ressli J, Prochazka L et. al. Intermittent high altitude hypoxia. Chest 1983; 77: 383-389.

  31. Kay JM, Effect of intermittent normoxia on chronic hypoxic pulmonary, righ ventricular hypertrofhy and polycythemia in rats. Am Rev Resp Dis 1980; 121: 993-1001.

  32. Fletcher EC, Schaaf JM, Millers J, Fletcher JG. Longterm cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis 1987; 135: 525-533.

  33. Laks L, Lehrharft B, Grunstein RR. Pulmonary hypertension in obstructive sleep apnea. Eur Respir J I995; 8: 537-541

  34. Schroeder JS, Motta J, Guilleminault C. Hemodinamic studies in sleep apnea. In: Guilleminault C, Dement WC (eds). Sleep apnea syndromes. New York: Alan Liss, 1978; 177-196.

  35. Block JA. Respiratory disorders during sleep (Part I). Heart Lung 1980; 1011-1024.

  36. Rochester DF, Enson Y, Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Am J Med 1974; 57: 402-420.

  37. Chaouat A, Weitzenblum E, Krieger J. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Chest I996; 109: 380-386.

  38. Sandoval J, Bauerle O, Palomar A, Gomez A, Guerra M. Survival in primary pulmonary hypertension. Circulation 1994; 89: 1733-1744.

  39. Burrows B, Kettel LJ, Niden AH. Patterns of cardiovascular dysfunction in chronic obstructive pulmonary disease. New Engl J Med 1972; 286: 912-917.

  40. Naeije R. Should pulmonary hypertension be treated in COPD? In: Weir EK, Archer SL, Reeves JT (eds). Diagnosis and treatment of pulmonary hypertension. New York: Futura Publishing, 1992: 209-218.

  41. Lupi-Herrera E, Sandoval J, Seoane M. Role of isoproterenol in the preoperative evaluation of high pressure, high resistance ventricular septal defect. Chest 1982; 81: 42-46.




2020     |     www.medigraphic.com